Imeik Technology DevelopmentLtd Past Earnings Performance
Past criteria checks 2/6
Imeik Technology DevelopmentLtd has been growing earnings at an average annual rate of 13.3%, while the Biotechs industry saw earnings declining at 5% annually. Revenues have been growing at an average rate of 16.3% per year. Imeik Technology DevelopmentLtd's return on equity is 13.7%, and it has net margins of 47.3%.
Key information
13.32%
Earnings growth rate
12.91%
EPS growth rate
Biotechs Industry Growth
11.29%
Revenue growth rate
16.28%
Return on equity
13.70%
Net Margin
47.28%
Next Earnings Update
21 Aug 2026
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Imeik Technology DevelopmentLtd makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
XSEC:300896 Revenue, expenses and earnings (CNY Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
31 Mar 26
2,423
1,146
622
370
31 Dec 25
2,453
1,291
568
360
30 Sep 25
2,515
1,465
451
354
30 Jun 25
2,668
1,626
408
334
31 Mar 25
2,881
1,874
399
305
31 Dec 24
3,026
1,958
398
304
30 Sep 24
3,075
2,026
376
278
30 Jun 24
3,067
2,016
383
272
31 Mar 24
3,047
1,972
390
264
31 Dec 23
2,869
1,858
409
250
30 Sep 23
2,620
1,695
422
217
30 Jun 23
2,513
1,642
398
213
31 Mar 23
2,138
1,404
332
188
01 Jan 23
1,939
1,264
291
173
30 Sep 22
1,914
1,236
276
156
30 Jun 22
1,699
1,118
258
123
31 Mar 22
1,619
1,061
258
108
01 Jan 22
1,448
958
221
102
30 Sep 21
1,268
858
189
90
30 Jun 21
1,101
718
164
85
31 Mar 21
889
567
134
78
31 Dec 20
709
440
114
62
30 Sep 20
627
376
113
51
31 Dec 19
558
306
126
49
31 Dec 18
321
123
107
34
31 Dec 17
222
82
68
28
31 Dec 16
141
53
60
0
31 Dec 15
112
18
74
0
Quality Earnings: 300896 has high quality earnings.
Growing Profit Margin: 300896's current net profit margins (47.3%) are lower than last year (65%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 300896's earnings have grown by 13.3% per year over the past 5 years.
Accelerating Growth: 300896's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 300896 had negative earnings growth (-38.9%) over the past year, making it difficult to compare to the Biotechs industry average (-6.1%).
Return on Equity
High ROE: 300896's Return on Equity (13.7%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/07/06 20:51
End of Day Share Price
2026/07/06 00:00
Earnings
2026/03/31
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Imeik Technology Development Co.,Ltd. is covered by 23 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.